Ledger.Open graph →
SEC Form D · filed December 2, 2022

FOG PHARMACEUTICALS, INC

Offering
$178.0M
Sold
$178.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Jeffrey A. Leerink · Cambridge, MADirectorAlliance Equities Corporation · Overland Park, KSDirectorJennifer Myung · Boulder, CODirectorGregory L. Verdine · Cambridge, MAExec · DirectorRick M. Klausner · Cambridge, MADirectorJihan Bowes-Little · West Hollywood, CADirectorBarbara M. Weber · Cambridge, MADirectorMagnus Hillestad · Palo Alto, CAExecCorey S. Goodman · Cambridge, MADirectorDeirdre M. Cummings · San Francisco, CADirectorRodney Thompson · Boulder, COExecChristopher Hunt · Stamford, CTDirectorKrishna M. Yeshwant · Cambridge, MADirectorRick M. Klausner · Cambridge, MADirectorAnselme Le Van · Mountain View, CAExec · DirectorBarry Gainsburg · Plantation, FLDirectorEdward M. Fitzgerald · Cambridge, MADirectorMargaret Regalia · Englewood, COExec · DirectorCorey S. Goodman · Cambridge, MADirectorWeiqing M. Zhou · Cambridge, MAExecBrent Watts · Savannah, GADirectorSimen S. Skogsrud · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗